Experiment | Labeling Density | Associated Figure | Mouse Line | Tamoxifen Dose | Admin. Route | Admin. Age |
---|---|---|---|---|---|---|
Aδ-LTMR labeling in sections | High | Fig. S2 | TrkBCreERT2;R26iAP | 2 doses of 2 mg | P.O. (Maternal) | E12.5, E13.5 |
Aδ-LTMR fluorescent sparse labeling | Low | Figure 4 | TrkBCreERT2;Ai140D | 0.75 mg | P.O. (Maternal) | E13.5 |
Aδ-LTMR Cell Body Labeling | High | Figure 5 B, E, F | TrkBCreERT2;R26iAP | 3 doses of 0.5 mg | I.P | P6, P7, P8 |
Aδ-LTMR RF sparse labeling | Low | Figure 6 A-D | TrkBCreERT2; R26iAP | 0.5 mg | P.O. (Maternal) | E13.5 |
C-LTMR RF sparse labeling | Low | Figure 6 E–H | THCreER; R26iAP | 2 doses of 2 mg | P.O | P14, P15 |